Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shifu Chen

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|January 6, 2021
The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovaryBing Wang, Jianfei Yao, Ruiqing Ma, et al.
Journal of Cancer Research and Clinical Oncology|February 27, 2022
The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patientsGuowu Wu, Longhua Guo, Yinfang Gu, et al.
The Oncologist|September 30, 2020
Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic AnalysisXiao-Dong Jiao, Ke Liu, Mingyan Xu, et al.
Cancer Research|May 24, 2018
Detection of Urothelial Bladder Carcinoma via Microfluidic Immunoassay and Single-Cell DNA Copy-Number Alteration Analysis of Captured Urinary-Exfoliated Tumor CellsAnqi Chen, Guanghou Fu, Zhijie Xu, et al.
Translational Lung Cancer Research|July 18, 2020
The contribution of hereditary cancer-related germline mutations to lung cancer susceptibilityMengyuan Liu, Xinyi Liu, Peisu Suo, et al.
Theranostics|June 7, 2021
Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLCYayi He, Linsong Chen, Lishu Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2021
Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung CancerYayi He, Lele Song, Hao Wang, et al.
Gut|September 7, 2021
Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatmentFeng Wang, You-Sheng Huang, Hao-Xiang Wu, et al.
Oral Oncology|November 4, 2022
Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencingBian Wu, Liangfang Shen, Gang Peng, et al.
European Radiology|August 24, 2022
Image-based deep learning identifies glioblastoma risk groups with genomic and transcriptomic heterogeneity: a multi-center studyJing Yan, Qiuchang Sun, Xiangliang Tan, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|January 6, 2021
The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovaryBing Wang, Jianfei Yao, Ruiqing Ma, et al.
Journal of Cancer Research and Clinical Oncology|February 27, 2022
The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patientsGuowu Wu, Longhua Guo, Yinfang Gu, et al.
The Oncologist|September 30, 2020
Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic AnalysisXiao-Dong Jiao, Ke Liu, Mingyan Xu, et al.
Cancer Research|May 24, 2018
Detection of Urothelial Bladder Carcinoma via Microfluidic Immunoassay and Single-Cell DNA Copy-Number Alteration Analysis of Captured Urinary-Exfoliated Tumor CellsAnqi Chen, Guanghou Fu, Zhijie Xu, et al.
Translational Lung Cancer Research|July 18, 2020
The contribution of hereditary cancer-related germline mutations to lung cancer susceptibilityMengyuan Liu, Xinyi Liu, Peisu Suo, et al.
Theranostics|June 7, 2021
Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLCYayi He, Linsong Chen, Lishu Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2021
Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung CancerYayi He, Lele Song, Hao Wang, et al.
Gut|September 7, 2021
Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatmentFeng Wang, You-Sheng Huang, Hao-Xiang Wu, et al.
Oral Oncology|November 4, 2022
Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencingBian Wu, Liangfang Shen, Gang Peng, et al.
European Radiology|August 24, 2022
Image-based deep learning identifies glioblastoma risk groups with genomic and transcriptomic heterogeneity: a multi-center studyJing Yan, Qiuchang Sun, Xiangliang Tan, et al.
Pageof 12